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Abstract
Unlike some organs, the heart is unable to repair itself after injury. Human embryonic stem cells (hESCs) grow and divide
indefinitely while maintaining the potential to develop into many tissues of the body. As such, they provide an
unprecedented opportunity to treat human diseases characterized by tissue loss. We have identified early myocardial
precursors derived from hESCs (hMPs) using an a-myosin heavy chain (aMHC)-GFP reporter line. We have demonstrated by
immunocytochemistry and quantitative real-time PCR (qPCR) that reporter activation is restricted to hESC-derived
cardiomyocytes (CMs) differentiated in vitro, and that hMPs give rise exclusively to muscle in an in vivo teratoma formation
assay. We also demonstrate that the reporter does not interfere with hESC genomic stability. Importantly, we show that
hMPs give rise to atrial, ventricular and specialized conduction CM subtypes by qPCR and microelectrode array analysis.
Expression profiling of hMPs over the course of differentiation implicate Wnt and transforming growth factor-b signaling
pathways in CM development. The identification of hMPs using this aMHC-GFP reporter line will provide important insight
into the pathways regulating human myocardial development, and may provide a novel therapeutic reagent for the
treatment of cardiac disease.
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Introduction
Over five million people in the United States alone suffer with
heart failure [1] because unlike some organs, the heart is unable to
repair itself after injury [2]. Human embryonic stem cells (hESCs)
grow and divide indefinitely while maintaining the potential to
develop into many tissues of the body. As such, they provide an
unprecedented opportunity to treat a variety of human diseases
characterized by tissue loss or insufficiency. Animal studies have
shown that pluripotent hESCs have a high risk of tumor formation
[3], while fully differentiated hESC-derived cardiomyocytes (CMs)
confer only modest functional benefit [4]. This suggests that from
a developmental standpoint, mature CMs may be beyond the
ability to fully incorporate into existing muscle. Therefore, the
identification of hESC-derived myocardial precursors that are
committed to the cardiac lineage, but retain the plasticity to
facilitate complete engraftment has been an important goal [5].
Work over the past decade has shown that hESCs differentiate
into a heterogeneous population of CMs in culture, with gene
expression patterns and electrophysiological properties reminis-
cent of embryonic atrium, ventricle and specialized conduction
tissue [6,7,8,9,10]. The mechanisms that drive CM subtype
specification, however, are not well understood.
To approach both the need for a model system with which to
elucidate the process of human CM subtype specification, and
provide a source of human myocardial precursors for cell therapy
studies, we engineered a hESC line that identifies multipotent
myocardial precursor (hMP) cells. These cells give rise to multiple
CM subtypes, and is therefore uniquely suited to address both of
these needs.
Results
Construction of an a-myosin heavy chain human
embryonic stem cell reporter line
The a-myosin heavy chain (aMHC) gene has been shown to be
expressed both early and late during murine cardiac development
[11,12]. Taking advantage of this developmentally broad expres-
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16004sion pattern, we used a subsequence of the murine aMHC
promoter consisting of nucleotides 21679 through +1 relative to
the translation start site of the aMHC mRNA to construct a
myocardial-specific enhanced GFP reporter in the H9 hESC line.
This contains MEF1 and MEF2 binding sites, two thyroid
hormone response elements, the cardiac troponin T-responsive
MCAT element, and SRF binding motif [13]. We used the HIV-
derived, self-inactivating lentiviral vector, 2K7bsd [14], in which
the HIV gag, pol, and env genes are deleted and the HIV-1 flap
sequence and woodchuck hepatitis virus post-transcriptional
regulatory element are included to improve infectious titer and
gene expression. To mitigate against the effects of clonal variation,
we isolated stable transfectants by population selection. Presum-
ably, cells in which viral integration disrupted essential genes did
not survive selection. Upon differentiation of the resulting aMHC-
GFP hESC line by human embryoid body (hEB) formation, GFP
expression was detected solely in 14 day hEBs co-expressing
cardiac troponin T (cTnT) (Fig. 1).
The aMHC-GFP reporter is activated solely in hESC-
derived cardiomyocytes
To specifically localize cardiac versus non-cardiac proteins
within differentiating aMHC-GFP
+ hEBs, and confirm that GFP
did not inhibit the expression of non-cardiac markers, we
determined co-localization of alpha-fetoprotein, a marker of
primitive endoderm, nestin, a marker of neuroectoderm, and
smooth muscle actin, a marker of non-cardiac mesoderm, with
GFP in the reporter line, compared to the co-localization of these
proteins with ubiquitin C-driven, constitutive expression of GFP in
a ubiC-GFP hESC line at day 14 of hEB differerentiation. This
demonstrated that while CM-specific cTnT, but not smooth
muscle actin, alpha-fetoprotein or nestin, co-localized with
aMHC-driven GFP expression in the aMHC-GFP reporter line,
all of these markers co-localized with ubiquitin C-driven GFP
expression in the ubiC-GFP line (Fig. 1). This also confirmed that
the absence of smooth muscle actin, alpha-fetoprotein or nestin co-
expression with aMHC-GFP was not due to interference by GFP
expression.
To determine the fate of selected aMHC-GFP
+ hEBs, we sorted
hEBs for GFP expression at day 8 of differentiation, then re-
cultured aMHC-GFP
+ cells under differentiation conditions for an
additional 6 days (day 14 of hEB differentiation) and assessed CM-
specific cTnT and cardiac a-actinin expression by in situ
immunocytochemistry. This showed that cells activating the
reporter on day 8 generated a lawn of cTnT
+ cardiac a-actinin
+
CMs in culture (Fig. 2), and that these cells demonstrate
spontaneous contractile activity (Movie S1 and S2).
aMHC-GFP-derived myocardial precursors give rise to
muscle in vivo
To establish that hESCs expressing the aMHC-GFP reporter
also give rise to muscle in vivo, we evaluated undifferentiated
aMHC-GFP hESCs by teratoma assay. We grafted 10
6 hESCs
beneath the kidney capsule of 8-week-old SCID mice, and
analyzed for teratoma formation after 10 weeks. The aMHC-
GFP hESCs consisted of tissues arising from all three embryonic
germ layers, however, indirect immunohistochemical analysis
showed that GFP expression was restricted to striated muscle,
specifically mononucleated myofibers characteristic of cardiac
muscle (Fig. 3). Restricted GFP localization to cardiac muscle in
all teratomas analyzed also suggested that hESCs expressing the
aMHC-GFP reporter do not form tumors comprised of other
tissues.
aMHC-GFP hESCs remain genetically stable
It is well-established that hESCs maintained in culture are at
risk for developing aneuploidy [15,16]. Therefore, it becomes
especially important to confirm genomic stability in any hESC-
derived line to be used for either developmental investigation or
therapy. To assess the genomic integrity of the aMHC-GFP hESC
Figure 1. The aMHC-GFP reporter line is cardiac-specific. hESCs from either the aMHC-GFP or UbiC-GFP reporter lines were differentiated for
14 days by hEB formation, and analyzed by direct and indirect immunofluorescence for expression of GFP and cTnT, SMA, AFP or nestin, respectively.
Cells were counterstained with DAPI to identify nuclei. Typical micrographs are shown. Co-localization of GFP solely with cardiac troponin T, but not
SMA, AFP or nestin, was seen in differentiated aMHC-GFP hESCs. In contrast, co-localization of GFP with all four markers was seen in differentiated
UbiC-GFP hESCs. Bar, 100 mm.
doi:10.1371/journal.pone.0016004.g001
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losses by array comparative genomic hybridization [17]. This
showed that aMHC-GFP hESCs maintain a normal karyotype at
the level of individual gene regions (Fig. 4).
The aMHC-GFP reporter identifies an early myocardial
precursor that gives rise to multiple CM subtypes
Others have shown that CMs derived from hESCs in culture
can display the molecular and electrical properties of embryonic
ventricular, atrial and nodal tissue [6]. This heterogeneity occurs
with differentiation in culture using a variety of conditions
[7,8,9,10], and suggests that hESCs are capable of giving rise to
myocardial precusors that precede the developmental branchpoint
between first and second heart field specification. We counted the
number of GFP
+ (aMHC
+) hESCs over the course of hEB
differentiation, and found that these cells started to appear in
culture at day 5, commensurate with the onset of GATA4 and
NKX2-5 expression, and several days before the expression of
cTnT, which is associated with spontaneous contractile activity
[18] (Fig. 5).
Since the reporter appeared to identify early human myocardial
precursors (hMPs), we wanted to determine whether these hMPs
Figure 2. Sorted aMHC-GFP
+ hESCs form CMs in vitro. aMHC-GFP hESCs were cultured under differentiation conditions for 8 days. (A) Day 8
hEBs were suspended as single cells and sorted for GFP expression. Propidium iodide was used to discriminate live versus dead cells. A typical sort is
shown. (B) GFP
+ cells were re-cultured under differentiation conditions for an additional 6 days, then analyzed in situ by indirect immunofluorescence
for expression of cTnT and cardiac a-actinin. Cells were counterstained with DAPI to identify nuclei. Typical micrographs are shown. Expression of
cTnT and cardiac a-actinin was seen throughout the culture, which demonstrated multiple foci of spontaneous contractile activity (Supplementary
Videos 1 and 2). Bar, 400 mm.
doi:10.1371/journal.pone.0016004.g002
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CMs based on molecular and electrical characteristics. We
differentiated aMHC-GFP hESCs for 21 days, and manually
dissected GFP
+ hEBs for analysis by qPCR and microelectrode
array. Evaluation of individual GFP
+ hEBs by qPCR demonstrat-
ed that molecular signatures characteristic of embryonic atrial
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To determine whether the electrical properties of GFP
+ hEBs
were similarly heterogeneous in nature, we allowed dissected hEBs
to adhere to microelectrode arrays (MEAs) (Fig. 6B) and
performed simultaneous recording of extracellular field potentials
Figure 3. hMPs form muscle in vivo. Teratomas formed from aMHC-GFP hESCs by renal capsule grafting in SCID mice were analyzed by
hematoxylin and eosin staining to identify tissue structures (left), and immunohistochemistry with anti-GFP antibody (right) to identify tissues arising
from hMPs. Section from typical teratoma shown (n=7). Primitive neural epithelium (star) and glandular intestinal structures (arrowheads) can be
seen surrounding striated muscle (arrows) (left), which stains positive for GFP expression (brown; right). GFP was expressed exclusively in
mononucleated myofibers within the teratomas, and was not found in any other tissues (not shown). Bar, 100 mm.
doi:10.1371/journal.pone.0016004.g003
Figure 4. The aMHC-GFP reporter line maintains genomic integrity. aMHC-GFP hESCs (H9; 46,XX) passaged ten times after stable selection
were analyzed by array comparative genomic hybridization. The log2 ratios for all loci on the array were plotted in genome order from chromosome
1pter to Xqter. The data were normalized so that the log2 ratio=0 for genomic regions that are present in diploid copy number. Male reference DNA
was used in the hybridization as indicated by the sex mismatch for chromosome X (arrow). There was no evidence of copy loss or gain, consistent
with maintenance of euploidy.
doi:10.1371/journal.pone.0016004.g004
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largest negative peak (FPmin), the last postive peak of the cycle
(FPmax), the time interval between FPmin and FPmax (FPdur), and
decay of the extracellular potential (time from the onset of the FP
to FPmin=FP rise). Others have shown that FPrise directly correlates
to action potential rise time, and FPdur directly correlates to action
potential duration [19,20]. Compared to HL-1 cells, which
represent a homogenous culture of mouse atrial CMs [21] with
FPdur#75 ms and FPrise#50 ms, both aMHC-GFP
+ and wild
type, beating hEBs demonstrated similarly heterogeneous combi-
nations of FPdur (25–250 ms versus 10–475 ms; p=0.86) and
FPrise (10–175 ms versus 10–275 ms; p=0.83) (Fig. 6D).
Expression profiling of human CM differentiation
Since we had established that this aMHC-GFP hESC line could
identify myocardial precusors capable of giving rise to all
embryonic CM subtypes, we used it to examine potential pathways
involved in CM differentiation. We isolated hMPs at day 8 of
differentiation, after the onset of GATA4, NKX2-5 and aMHC
expression, but before cTnT expression or spontaneous contrac-
tions (Fig. 5), and at day 14 of differentiation, after the onset of
cTnT expression and spontaneous beating (Fig. 1), and compared
the gene expression profiles of these two differentiation time points
to each other and to undifferentiated hESCs using an array of
.41,000 unique sequences representing the whole human
genome. Analysis of the 830 most highly differentially expressed
genes from biological replicates of each time point resulted in the
clustering shown in Fig. 7. This indicated that the reproducibility
of hMP differentiation was reasonably robust. Overall, there were
3,279 probes targeting human genes that showed differential
expression across the three time points with a false discovery rate
,0.05. The complete data set has been deposited in Gene
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/; Acces-
sion Number GPL6480).
Analysis of cardiac-specific gene expression demonstrated that
hMP differentiation proceeded in a manner commensurate with
cardiac morphological development (Table 1). Differentiating
hMPs expressed markers of cardiac tube formation (NKX2-5,
GATA4) and looping (MEF2c, aMHC) by day 8, and markers of
spontaneous contractile activity (cTnT, cTnI) by day 14. In
addition, expression levels of atrial (ISL-1, ANF) and right
ventricular (ISL-1, HAND2) genes were observed by day 8 and
continued to rise through day 14, while expression of genes
associated with development of the atrioventricular septum
(TBX2) and left ventricle (HAND1, TBX5) were observed by
day 14.
The role of Wnt signaling during myocardial specification and
early cardiac morphogenesis has been described [22]. Wnt ligands
and Frizzled receptors specifically have been implicated during
early heart development. This is supported by our findings that the
expression of Wnt1, 2, 5B and 11, as well as Frizzled 4 and 5 was
Figure 5. Reporter activation coincides with early cardiogen-
esis. aMHC-GFP hESCs were differentiated for 12 days and the number
of hMPs (GFP
+aMHC
+) cells were scored as a percentage of total hESC
number on each day. On days 1–4, before the onset of GFP expression,
unsorted differentiating hESCs were analyzed by qPCR. On days 5–12,
sorted GFP
+ hMPs were analyzed by qPCR for expression of cTnT, NKX2-
5, GATA4 and aMHC, relative to undifferentiated hESCs at day 1. Data
shown represent mean6s.e.m. (N=3). Reporter activation was first
observed on day 5, with 15% GFP
+ (aMHC
+) hESCs seen by day 9 (top).
Endogenous aMHC, GATA4 and NKX2-5 expression was observed with
activation of the reporter on day 5, while strong expression of cTnT did
not appear until day 11 (bottom).
doi:10.1371/journal.pone.0016004.g005
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addition, secreted Frizzled-related proteins (SFRPs) that are
known to inhibit Wnt signaling and regulate CM proliferation,
were downregulated at day 8, but then upregulated in the case of
SFRP3 at day 14 (Table 2). CM migration during heart
development has been shown to rely on transforming growth
factor b (TGFb) signaling [23]. Consistent with its role in
cardiogenesis, several effectors and inhibitors of TGFb pathways
were upregulated and downregulated, respectively, over the course
of hMP differentiation (Table 3).
Discussion
Although b-myosin heavy chain (bMHC) is the predominant
isoform expressed during murine embryonic and fetal develop-
ment, the transition from bMHC to aMHC begins as early as day
7.5 p.c. in mouse embryos with the appearance of somites and the
onset of cardiac tube formation [11,12]. Expression of both
isoforms approaches equivalence as the cardiac tube begins to
contract by day 9.5 p.c., and the b/a ratio begins to reverse with
aMHC becoming the predominant isoform during postnatal life
[11,12]. These observations during mouse development in vivo
parallel mouse ESC (mESC) differentiation in vitro. aMHC is
expressed by day 8 of mESC differentiation and is expressed
exclusively in beating mouse EBs [12]. While many studies have
used the murine aMHC promoter to track mature CMs, our data
suggest that because of its expression across early and mature
stages of CM development even between species, the murine
aMHC promoter can be used to track CM differentiation from a
Figure 6. hMPs give rise to multiple CM subtypes. aMHC-GFP or wild type hESCs were differentiated for 21 days, and beating GFP
+ or wild type
hEBs were manually dissected for further analysis. (A) GFP
+ hEBs were analyzed for expression of Islet-1 (ISL-1), sarcolipin (SLN), Na
+/K
+
hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4), myosin light chain-2 atrial (MLC2a), MLC2v, aMHC and cTnT, relative to
undifferentiated hESCs. Gene expression patterns consistent with embryonic atrium, sinoatrial (SA) node, left (LV) and right (RV) ventricle were seen.
Data shown represent mean6s.e.m. for at least three hEBs with similar expression profiles for these seven genes. (B) A typical GFP
+ hEB cultured on a
gelatin-coated microelectrode array for 2 days is shown. (C) Sample field potential (FP) tracings recorded at arrayed microelectrodes are shown for
HL-1 cells and typical aMHC-GFP
+ or wild type hEBs. (D) Field potentials of averaged HL-1 cultures or hEBs were analyzed, and the number of tracings
with a given FP duration (FPdur) or decay of extracellular potential (FPrise) were plotted as a function FPdur (left)o rF P rise (right). Compared to the
homogeneous FP recordings of HL-1 cultures, both aMHC-GFP
+ (n=7) and wild type (n=5) hEBs showed similarly heterogeneous, averaged FP
recordings, consistent with a heterogeneous distribution of action potential durations extracellular potential decay.
doi:10.1371/journal.pone.0016004.g006
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us an unprecedented opportunity to study human CM differen-
tiation from undifferentiated ESCs through EB formation and
ultimately embryonic CM subtypes.
Other laboratories have developed transgenic/reporter hESC
lines to derive differentiated CMs. As distinct from the work
described here, however, these lines have allowed either for the
selection of mature CMs only, or of progenitors that give rise to
non-muscle cardiac cells in addition to myocardial cells. Huber
et al. used lentiviral vectors to produce stable hESC lines in which
enhanced GFP was expressed under control of the MLC2v
promoter [24]. While these lines were able to generate electrically
active CMs of unspecified subtype, MLC2v is expressed later in
CM differentiation than aMHC, and does not afford the same
insight into early CM differentiation. Xu et al. generated stable
hESC lines using a plasmid containing the aMHC promoter
driving expression of the neomycin resistance gene [25]. While this
afforded an effective strategy for enriching CMs for cell transplant
experiments, it does not accommodate the study of developmental
stages over time. Kita-Matsuo et al. recently reported the design of
a set of lentiviral vectors to generate multiple stable hESC lines
with eGFP and mCherry reporters or with puromycin resistance
using the aMHC promoter [26]. The focus of these studies was to
create tools to enhance CM production for large-scale clinical
application. While these investigators demonstrated that hESC-
derived CMs have gene expression profiles similar to those found
in adult hearts and electrophysiological properties of embryonic
CMs, analysis of CM differentiation using these lines was not
reported. To track the fate of human Isl1
+ cells and their progeny
during hESC differentiation, Bu et al. used Isl1:cre hESCs
transfected with a pCAG-flox-DsRed reporter plasmid to achieve
irreversible DsRed expression in Isl1
+ cells. In clonal assays of day
8 hEBs, about half of the DsRed
+ clones expressed markers of the
three major cardiac lineages, cTnT (CMs), PECAM1/CD31
(endothelial cells), and smooth muscle troponin (smooth muscle
cells) [27], suggesting the identification of a multipotent precursor
that is not restricted to the cardiac muscle lineage.
It has long been appreciated that hESCs differentiate into a
heterogeneous population of atrial, ventricular and specialized
conduction CMs in culture [6,7,8,9,10]. Whether this reflects a
stochastic process in vitro, and is driven by a combination of genetic
programming and the extracellular milieu in vivo, has not been
established. Understanding the mechanisms that drive CM
subtype specification, however, will be essential to both under-
standing cardiac development and developing cell-based reagents
for myocardial therapy.
In summary, we have identified multipotent human myocardial
precursors (hMPs) using an aMHC-GFP reporter hESC line. We
have demonstrated that reporter activation is restricted to hESC-
derived CMs differentiated in vitro and in vivo, and that the reporter
does not interfere with hESC genomic stability. Importantly, we
show that hMPs give rise to multiple CM subtypes and can be used
to explore CM differentiation on the molecular level by expression
profiling. These precursors will provide important insight into the
pathways regulating human myocardial development, and provide
a novel therapeutic approach to stem cell therapy for cardiac
disease.
Materials and Methods
hESC culture and differentiation
All work with hESCs was done with the approval of the UCSF
Stem Cell Research Oversight Committee. The parent H9 hESC
line (WA09; WiCell) was maintained on irradiated mouse
embryonic fibroblast (MEF) feeder cells (Millipore) in a medium
comprised of Knockout DMEM (Invitrogen) supplemented with
20% Knockout Serum Replacement (Invitrogen), 2 mM gluta-
mine, 0.1 mM nonessential amino acids, 0.1 mM b-mercaptoeth-
anol and 15 ng/ml recombinant human FGF-basic (R&D
Systems). Differentiation was initiated by human embryoid body
(hEB) formation in suspension as previously described [28].
Briefly, colonies of hESCs were dissociated into small clusters by
exposure to Collagenase IV (Sigma-Aldrich), then allowed to
differentiate in a medium comprised of Knockout DMEM
(Invitrogen) supplemented with 20% Defined Fetal Bovine Serum
(Hyclone), 2 mM glutamine, 0.1 mM non-essential amino acids,
and 0.1 mM b-mercaptoethanol. After 4–7 days in suspension,
hEBs were attached to gelatin-coated 12-well culture plates and
allowed to differentiate for an additional 14–21 days. For re-
culture and expression profiling experiments, hEBs were dissoci-
ated with TrypLE Express (Invitrogen) to generate single cell
suspensions, stained with propidium iodide to distinguish between
live and dead cells, and sorted on the basis of GFP expression
using a FACSAria (Becton Dickinson) with standard filter sets
using previously described methods [29,30].
Figure 7. Expression profiling of differentiating hMPs. Relative
gene expression in undifferentiated aMHC-GFP hESCs, hMPs sorted
from day 8 aMHC-GFP hEBs, and hMPs sorted from day 14 aMHC-GFP
hEBs (two samples each) was analyzed. Heat map shows log2-fold
change (sample intensity/mean intensity for undifferentiated group) for
the 830 genes that had statistically significant differences (false
discovery rate (FDR) ,0.05) of at least 2-fold in any pairwise comparison
between the three groups.
doi:10.1371/journal.pone.0016004.g007
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The 2K7bsd lentivector (kindly provided by David Suter [14])
was used to assemble a lentiviral plasmid capable of driving the
expression of enhanced green fluorescent protein (GFP) by a
ubiquitin-C or a-myosin heavy chain (aMHC) promoter. The
Table 2. Fold-changes in Wnt Pathway Genes.
Wnt Genes Day 8 v. Day 0 [FDR]* Day 14 v. Day 0 [FDR]
Effectors
Wnt1 17 [0.001] 32 [0]
Wnt2 47 [0] 26 [0]
Wnt2B - - 3 [0.039]
Wnt5A - - 5 [0.009]
Wnt5B 4 [0.005] 5 [0.002]
Wnt8B - - 4 [0.041]
Wnt11 8 [0.007] 10 [0.005]
Activin A receptor 4 [0.011] 4 [0.007]
N-cadherin 2 4 [0.042] - -
DKK2 - - 5 [0.022]
DKK3 5 [0.002] 7 [0.001]
Frizzled 4 4 [0.018] - -
Frizzled 9 5 [0.012] - -
Frizzled 10 - - 3 [0.017]
LEF1 15 [0.001] 20 [0]
NFATC2 4 [0.004] 5 [0.002]
NFATC4 - - 3 [0.011]
RARb - - 3 [0.045]
Inhibitors
PPP2CA 22 [0.045] 26 [0.046]
PPP2R1B 25 [0.013] 24 [0.027]
PPP2R2B 29 [0.002] 26 [0.003]
SFRP1 23 [0.017] - -
SFRP2 219 [0.006] 27 [0.001]
SFRP3 - - 5 [0.029]
SOX2 217 [0.001] 29 [0.002]
SOX3 212 [0.003] 25 [0.016]
SOX11 23 [0.018] - -
*FDR, false discovery rate.
doi:10.1371/journal.pone.0016004.t002
Table 3. Fold-changes in TGFb Pathway Genes.
TGFb Genes Day 8 v. Day 0 [FDR*] Day 14 v. Day 0 [FDR]
Effectors
TGFb23 1 [0] 51 [0]
TGFb34 [0.043] - -
Activin/Inhibin A 3 [0.013] - -
Activin A receptor 4 [0.011] 4 [0.007]
BMP2 16 [0] 18 [0]
BMP4 6 [0.013] 25 [0.001]
BMP5 65 [0] 135 [0]
BMP7 8 [0.003] 10 [0.002]
BMP10 14 [0.013] - -
SMAD3 - - 2 [0.022]
SMAD6 4 [0.019] - -
SMAD9 4 [0.007] 8 [0.001]
Id2 7 [0.003] - -
Id3 4 [0.012] - -
Id4 12 [0.001] - -
Inhibitors
MAP3K7 22 [0.038] - -
MAPK1 23 [0.038] - -
MAPK8 22 [0.027] - -
c-Myc 213 [0.001] 210 [0.001]
DP1 22 [0.050] 23 [0.017]
E2F4 23 [0.028] 23 [0.020]
*FDR, false discovery rate.
doi:10.1371/journal.pone.0016004.t003
Table 1. Fold-changes in Cardiac-Specific Genes.
Cardiac Genes Stage/Chamber* Day 8 v. Day 0 [FDR**] Day 14 v. Day 0 [FDR]
NKX2-5 tube 34 [0.002] 42 [0.001]
GATA4 tube 24 [0] 29 [0]
MEF2c loop 28 [0] 26 [0]
aMHC loop 841 [0] 886 [0]
cTnT contract -- 1 2 2 [0]
cTnI contract -- 3 2 [0]
ISL-1 A/RV 4 [0.012] 16 [0.001]
ANF A 82 [0] 317 [0]
HAND2 RV 232 [0] 476 [0]
TBX2 AV -- 4 6 [0]
HAND1 LV -- 3 3 [0]
TBX5 LV -- 7 4 [0]
*A, atrium; RV, right ventricle; AV, atrioventricular septum; LV, left ventricle.
**FDR, false discovery rate.
doi:10.1371/journal.pone.0016004.t001
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from the translation start site; [31]), amplified by PCR, or a 1.7 kb
EcoRI-SalI fragment from the mouse aMHC promoter (generously
provided by Jeffrey Robbins [13]) was inserted into the pENTR
59-TOPO entry vector using the pENTR 59-TOPO TA Cloning
Kit (Invitrogen). A cDNA encoding GFP was inserted into the
pENTR/D-TOPO entry vector using the pENTR/D-TOPO
Cloning Kit (Invitrogen). The promoters and reporter gene were
inserted into the double recombination site of the 2K7bsd plasmid
using LR Clonase Plus Enzyme Mix (Invitrogen) according to the
manufacturer’s instructions.
Immunocytochemistry
The lineage fate of differentiated hEBs was determined by
staining 14-day-old, adherent differentiating hEBs attached to
cover slips in 12-well culture plates. Cover slips were fixed with
4% paraformaldehyde, then permeabilized with 50% methanol/
50% PBS, then 100% methanol, then 50% methanol/50% PBS/
0.1% Triton X-100, and finally PBS/0.1% Triton X-100. hEBs
were incubated with blocking buffer (PBS/10% horse serum/1%
BSA/0.1% Triton X-100), then with primary antibody (1–5 mg/
ml) in blocking buffer. Primary antibodies used were mouse anti-
human cardiac troponin T (LabVision/Neomarkers MS-295-P1;
clone 13–11), mouse anti-human cardiac a-actinin (Sigma
A7732; clone EA-53), mouse anti-human alpha-fetoprotein
(Sigma A8452; clone C3), mouse anti-human nestin (R&D
Systems MAB1259; clone 196908) or mouse anti-human smooth
muscle actin (R&D Systems MAB1420; clone 1A4). Cover slips
were washed with blocking buffer, incubated with 1:500 dilution
of goat anti-mouse Alexa-Fluor 594 (Invitrogen A20185), washed
with PBS/1% Triton X-100, then mounted with PBS and DAPI
and analyzed by confocal microscopy using a Zeiss LSM510
META system. Alternatively, 8-day-old differentiating hEBs were
sorted for GFP expression and re-cultured in differentiation
medium in the presence of 10 mM p160 Rho-associated coiled-
coil kinase inhibitor (Calbiochem 688000; Y-27632). At 14 days,
differentiating hEBs were stained in situ in culture plates as
described above using the same antibodies, and analyzed by
immunofluorescence microscopy using a Nikon Microphot-FXA
fluorescence/phase microscope and QImaging Retiga 2000R
digital camera (Diagnostic Instruments) with MetaMorph soft-
ware (Molecular Devices).
Teratomas
All experiments involving animals were done with the approval
of the UCSF Institutional Animal Care and Use Committee. To
form teratomas, 5610
5 hESCs were mixed with an equal volume
of 1 mg/ml Phaseolus vulgaris lectin (PHA-P L1668; Sigma),
pelleted, and incubated in growth medium overnight at 37uC,
5% CO2 in a 0.4 mm MILLICELL (Millipore). At least 2 cell
pellets were grafted under each kidney capsule of 8-week-old
female CB17 SCID-Beige mice (n=7) using published techniques
[32]. Transplanted cells formed teratomas in the recipients and
were analyzed 10 weeks after grafting. Teratomas were fixed in
10% buffered formalin, embedded in paraffin, and 5 mm sections
were stained with purified polyclonal rabbit anti-GFP (Molecular
Probes A11120) at 1:1500 and biotinylated goat anti-rabbit IgG
(Vector BA-1000). Slides were developed using the VECTAS-
TAIN Elite ABC kit (Vector) and counterstained with hematoxylin
and eosin to identify tissue structures.
Quantitative real-time PCR
For analysis of transcript expression, GFP
+ hESCs were sorted
by FACS at indicated time points, or beating areas from
approximately 20 hEBs were visualized with a Leica MZ6
microscope and manually excised using an 18 g needle. The
collected tissue samples were treated with 0.05% Trypsin-EDTA
to generate a single cell suspension prior to RNA isolation. RNA
was isolated and cDNA synthesized from ,50,000 hEB-derived
cells or proliferating hESCs using the Taqman Gene Expression
Cells-to-CT kit (Ambion). cDNA was quantitated using a
Nanodrop ND-1000 Spectrophotometer (Nanodrop Technolo-
gies, ND Software version 3.3.0). Linear pre-amplification of
target sequences was accomplished using the Applied Biosystems
PreAmp system. Relative expression was determined using the
TaqMan Assay (Applied Biosystems) on an ABI 7300 Real-Time
PCR system with the following primer pairs (ABI): GATA4
(Hs00171403_m1), NKX2-5 (Hs00231763_m1), Is ˜l1Hs 010996-
87_m1;Hs00158126_m1sarcolipin (Hs00161903_m1;Hs0188846-
4_s1), HCN4 (Hs00975492_m1;Hs00175760_m1), MLC2a (Hs0-
0221909_m1), MLC2v (Hs00166405_m1;Hs01125721_m1), aM-
HC (Hs00411908_m1), cTnT (Hs00165960_m1), smooth muscle
actin (Hs00242273_m1), a-fetoprotein (Hs00173490_m1), nestin
(Hs00707120_s1), a1 integrin (Hs00235030_m1), a2 integrin
(Hs00158148_m1), a4 integrin (Hs00168433_m1), a5 integrin
(Hs00233732_m1), a6 integrin (Hs01041011_m1), a7 integrin
(Hs00174397_m1), av integrin (Hs00233790_m1), b1 integrin
(Hs00559595_m1), b5 integrin (Hs00609896_m1), and GAPDH
(4326317E). Cycle times to detection were normalized against a
reference gene, GAPDH, and relative changes were calculated
using ABI Version 1.4 Sequence Detection Software.
Microelectrode array analysis
Individual GFP-expressing and wild type hEBs demonstrating
contractile activity were mechanically dissected and plated on
fibronectin-coated microelectrode arrays (MEA; Multi Channel
Systems, Reutlingen, Germany). Mouse atrial HL-1 cells (gener-
ously provided by William Claycomb, LSU Health Sciences
Center) were cultured on MEAs as control. The MEA system
consisted of a 50650 mm glass substrate with an embedded
1.461.4 mm matrix of 60 titanium nitride-gold contact electrodes
with interelectrode distance of 200 mm. This allowed for
simultaneous recording of extracellular field potentials (FP) from
all electrodes over extended periods of time. Spontaneous
electrical activity was recorded at 10 kHz. The temperature was
kept at 37uC. Analysis of recordings was done using MC_Rack
(Multi-Channel Systems) and a customized toolbox for MATLAB.
The following parameters were determined: size of the largest
negative peak (FPmin), last postive peak of the cycle (FPmax), the
time interval between FPmin and FPmax (FPdur), and decay of
extracellular potential (time from the onset of the FP to
FPmin=FP rise) [19,20].
Array comparative genomic hybridization
Genomic DNA (300–500 ng) from the aMHC-GFP reporter
hESC line was isolated using the Qiaeasy DNA kit for tissue
(Qiagen). DNA was labeled with Cy3 and Cy5 using the BioPrime
DNA labeling system (Invitrogen), hybridized to HumArray 3.2
Human chromosome arrays, and analyzed for chromosomal
composition. Differentially labeled human male reference genomic
DNA was run as a control. The HumArray 3.2 array contains
2,464 bacterial artificial chromosome clones spotted in triplicate
and distributed uniformly across the genome. Each clone contains
at least one STS and is mapped to the human genome sequence.
Clones containing unique sequences near the telomeres and genes
known to be significant in cancer and medical genetics are
included on these arrays.
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Sample preparation, labeling, and array hybridizations were
performed according to standard protocols from the UCSF Shared
Microarray Core Facilities and Agilent Technologies (http://
www.arrays.ucsf.edu and http://www.agilent.com). Total RNA
quality was assessed using a Pico Chip on an Agilent 2100
Bioanalyzer (Agilent Technologies). RNA was amplified using the
Sigma whole transcriptome amplification kit following the
manufacturer’s protocol (Sigma-Aldrich), and subsequent Cy3-
CTP labeling was performed using the NimbleGen one-color
labeling kit (Roche-NimbleGen). The size distribution and
quantity of the amplified product was assessed using an Agilent
2100 Bioanalyzer and a Nanodrop ND-8000 (Nanodrop Tech-
nologies); the labeled DNA was assessed using the Nandrop 8000,
and equal amounts of Cy3 labeled target were hybridized to
Agilent human whole genome 4644 K Ink-jet arrays. Hybridiza-
tions were performed for 14 hrs, according to the manufacturers
protocol. Arrays were scanned using an Agilent microarray
scanner and raw signal intensities were extracted with Feature
Extraction v.10.1 software (Agilent Technologies). Data were
further analyzed using Ingenuity Pathways Analysis (IngenuityH
Systems) to identify biological pathways involved in CM
differentiation. The false discovery rate (FDR) from the data set
was used for canonical pathways analysis.
Statistics
Student’s t-test was used to compare the means of the frequency
count distributions of FPdur and FPrise. A value of p,0.05 was
considered significant. These analyses were performed using SPSS
v.16 (SPSS, Inc.) for Macintosh.
The mRNA expression array dataset was normalized using the
quantile normalization method [33]. No background subtraction
was performed, and the median feature pixel intensity was used as
the raw signal before normalization. A one-way ANOVA linear
model was fit to the comparison to estimate the mean M values
and calculated FDR for each gene for the comparison of interest.
All procedures were carried out using functions in the R package
limma in Bioconductor [34,35].
Supporting Information
Movie S1 Sorted aMHC-GFP
+ hESCs form beating CMs
in vitro. aMHC-GFP hESCs were cultured under differentiation
conditions for 8 days, suspended as single cells and sorted for GFP
expression. GFP
+ cells were re-cultured under differentiation
conditions for an additional 6 days, then analyzed in situ by phase
contrast video microscopy. A typical culture demonstrating
multiple foci of spontaneous contractile activity is shown.
Magnification, 10X.
(MOV)
Movie S2 Sorted aMHC-GFP
+ hESCs form beating CMs
in vitro. Conditions as described for Movie S1. A typical culture
demonstrating multiple foci of spontaneous contractile activity is
shown at lower magnification. Magnification, 4X.
(MOV)
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